BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38777829)

  • 1. Guidelines for Manufacturing and Application of Organoids: Heart.
    Lee HA; Woo DH; Lim DS; Oh J; Kim CY; Bae ON; Ahn SJ
    Int J Stem Cells; 2024 May; 17(2):130-140. PubMed ID: 38777829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential Guidelines for Manufacturing and Application of Organoids.
    Ahn SJ; Lee S; Kwon D; Oh S; Park C; Jeon S; Lee JH; Kim TS; Oh IU
    Int J Stem Cells; 2024 May; 17(2):102-112. PubMed ID: 38764240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for Manufacturing and Application of Organoids: Liver.
    Moon HR; Mun SJ; Kim TH; Kim H; Kang D; Kim S; Shin JH; Choi D; Ahn SJ; Son MJ
    Int J Stem Cells; 2024 May; 17(2):120-129. PubMed ID: 38773747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [hiPSCs and organoids: prediction of arrhythmogenic risks for optimized traditional Chinese medicine].
    Sun HK; Gao Y; Zhu MJ; Tang JF; Wu Y; Li B; Yu R; Wang Y; Zhou LY
    Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(20):5404-5409. PubMed ID: 38114134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for Manufacturing and Application of Organoids: Skin.
    Lee S; Rim YA; Kim J; Lee SH; Park HJ; Kim H; Ahn SJ; Ju JH
    Int J Stem Cells; 2024 May; 17(2):182-193. PubMed ID: 38783680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for Manufacturing and Application of Organoids: Lung.
    Lim K; Lee MO; Choi J; Kim JH; Kim EM; Woo CG; Chung C; Cho YH; Hong SH; Cho YJ; Ahn SJ
    Int J Stem Cells; 2024 May; 17(2):147-157. PubMed ID: 38777828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Central Nervous System Organoids: A Focus on Organoid-Based Models for Motor Neuron Disease.
    Vieira de Sá R; Cañizares Luna M; Pasterkamp RJ
    Tissue Eng Part C Methods; 2021 Mar; 27(3):213-224. PubMed ID: 33446055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The case for applying tissue engineering methodologies to instruct human organoid morphogenesis.
    Marti-Figueroa CR; Ashton RS
    Acta Biomater; 2017 May; 54():35-44. PubMed ID: 28315813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of doxorubicin toxicity using human cardiac organoids: A novel model for evaluating drug cardiotoxicity.
    Chen X; Lu N; Huang S; Zhang Y; Liu Z; Wang X
    Chem Biol Interact; 2023 Dec; 386():110777. PubMed ID: 37879593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for Manufacturing and Application of Organoids: Kidney.
    Kang HM; Kim DS; Kim YK; Shin K; Ahn SJ; Jung CR
    Int J Stem Cells; 2024 May; 17(2):141-146. PubMed ID: 38764433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposal for considerations during human iPSC-derived cardiac organoid generation for cardiotoxicity drug testing.
    Lee SW; Song M; Woo DH; Jeong GS
    Biomed Pharmacother; 2024 May; 174():116511. PubMed ID: 38574616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for Manufacturing and Application of Organoids: Brain.
    Kwak T; Park SH; Lee S; Shin Y; Yoon KJ; Cho SW; Park JC; Yang SH; Cho H; Im HI; Ahn SJ; Sun W; Yang JH
    Int J Stem Cells; 2024 May; 17(2):158-181. PubMed ID: 38777830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Challenges Associated with the Use of Human Induced Pluripotent Stem Cell-Derived Organoids in Regenerative Medicine.
    Lee H; Son MY
    Int J Stem Cells; 2021 Feb; 14(1):9-20. PubMed ID: 33632980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards manufacturing of human organoids.
    Ashok A; Choudhury D; Fang Y; Hunziker W
    Biotechnol Adv; 2020; 39():107460. PubMed ID: 31626951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the Ethical Issues of Brain Organoid Research and Application.
    Sawai T; Hayashi Y; Niikawa T; Shepherd J; Thomas E; Lee TL; Erler A; Watanabe M; Sakaguchi H
    AJOB Neurosci; 2022; 13(2):81-94. PubMed ID: 33769221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptomic Mapping of Neural Diversity, Differentiation and Functional Trajectory in iPSC-Derived 3D Brain Organoid Models.
    Kiaee K; Jodat YA; Bassous NJ; Matharu N; Shin SR
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Imperative for Innovative Enteric Nervous System-Intestinal Organoid Co-Culture Models: Transforming GI Disease Modeling and Treatment.
    Llorente C
    Cells; 2024 May; 13(10):. PubMed ID: 38786042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing prodrug metabolism and reciprocal toxicity with an integrated and humanized multi-tissue organ-on-a-chip platform.
    Rajan SAP; Aleman J; Wan M; Pourhabibi Zarandi N; Nzou G; Murphy S; Bishop CE; Sadri-Ardekani H; Shupe T; Atala A; Hall AR; Skardal A
    Acta Biomater; 2020 Apr; 106():124-135. PubMed ID: 32068138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of organoid technology in the human health risk assessment of microplastics: A review of progresses and challenges.
    Cong J; Wu J; Fang Y; Wang J; Kong X; Wang L; Duan Z
    Environ Int; 2024 Jun; 188():108744. PubMed ID: 38761429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Neurotoxicity With Human Pluripotent Stem Cell-Derived Cerebral Organoids.
    Parmentier T; LaMarre J; Lalonde J
    Curr Protoc; 2023 Apr; 3(4):e744. PubMed ID: 37068185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.